The event RX Drug Pricing Boot Camp on Thursday, May 17, 2007-Friday, May 18, 2007 at the Crowne Plaza Hotel in San Francisco, CA.  The event has been designed to give notices and  experienced practitioners alike a complete understanding of core pricing competencies and applicable changes in the reimbursement structures of key payor programs under recently enacted legislation.  The event will highlight the following:

• The Deficit Reduction Act and its impact on pricing methodologies relative to Medicaid and other payor programs.
• The role of the National Rebate Agreement in various payor programs.
• AWP: what is it, when is it still used, and what is its relationship to WAC?
• 340B entities: how are they defined and how is 340B pricing set?
• The essentials of Medicare Part B pricing, including the interrelation of ASP, CAP, and WAMP
• The ins and outs of government contracting relative to GSA FSS, VA/DOD, and Tricare
• Pricing concepts and reimbursement challenges relative to Medicare Part D, including: fraud and abuse risk areas — PAPs, off-label use, and Part D marketing guidelines; LTC pharmacies and PBMs; the position of CMS on legal issues affecting the drug benefit; formulary negotiations; and policy concerns.